Change In Magnitude Of Clinical Benefit, Overall Survival (Os) And Quality Of Life (Qol) Between Time Of Approval And Post-Marketing Among Cancer Drugs Approved By The Us Food And Drug Administration (Fda) 2006-2015
ANNALS OF ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要